MKI67 and neoplasm: Additionally, immunohistochemistry (IHC) results showed increased expression of Ki‐67, a marker of proliferation, in the tumor tissues of the ABL‐overexpressing group compared with that of the control group with or without cisplatin treatment (Figure 5G).